{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-242461","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2022-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.227713+00:00","generated_at":"2026-06-23T11:02:14.198394+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Acumen posts updated corporate presentation on website; no new material data disclosed","bullets":["Company posted updated corporate presentation dated September 2022 to its investor website on September 12, 2022.","Presentation may be used in communications or conferences; filing under Regulation FD.","No specific financial, clinical, or operational updates provided in the 8-K filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-242461","json":"https://secwatch.observer/filing/0001193125-22-242461.json","markdown":"https://secwatch.observer/filing/0001193125-22-242461.md","text":"https://secwatch.observer/filing/0001193125-22-242461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522242461/0001193125-22-242461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000119312522242461/d267556d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:02:14.198394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}